Trials / Completed
CompletedNCT05000190
Acute and Chronic Effect of 250 mg Citicoline Consumption on Attention in Adults: A Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary study objectives are to test whether among a sample of healthy adults consuming: (1) a single capsule containing 250 mg citicoline has an effect on attentional performance 1, 2 and 3 h post-dose compared to placebo (acute effect), and (2) capsule containing 250 mg citicoline per day for 28 consecutive days has an effect on attentional performance compared to placebo (chronic effect).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Active capsule | 1 capsule daily for 28 days |
| OTHER | Placebo capsule | 1 capsule daily for 28 days |
Timeline
- Start date
- 2021-09-13
- Primary completion
- 2022-07-19
- Completion
- 2022-07-19
- First posted
- 2021-08-11
- Last updated
- 2022-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05000190. Inclusion in this directory is not an endorsement.